Kalaris Therapeutics Inc

General ticker "KLRS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $131.6M (TTM average)

Kalaris Therapeutics Inc does not follow the US Stock Market performance with the rate: -36.1%.

Estimated limits based on current volatility of 10.2%: low 1.26$, high 1.55$

Factors to consider:

  • Total employees count: 20 as of 2025
  • Company does not operate outside US (retrieved using AI)
  • Top business risk factors: Operating losses, Clinical trial failure, Regulatory and compliance, Intellectual property risks, Sales and marketing challenges
  • Current price 71.7% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.84$, 14.99$]
  • 2026-12-31 to 2027-12-31 estimated range: [2.90$, 9.43$]

Financial Metrics affecting the KLRS estimates:

  • Negative: with PPE of -2.2 at the end of fiscal year the price was very high
  • Negative: negative Operating income
  • Negative: negative Operating cash flow
  • Positive: -18.01 < Investing cash flow per share per price, % of -14.02
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term KLRS quotes

Long-term KLRS plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $199.90MM $65.44MM $46.15MM
Operating Income $-199.90MM $-65.44MM $-46.15MM
Non-Operating Income $9.36MM $6.67MM $2.71MM
Interest Expense $0.00MM $0.00MM $1.44MM
R&D Expense $133.07MM $12.34MM $30.75MM
Income(Loss) $-190.54MM $-58.77MM $-43.44MM
Taxes $-0.13MM $0.00MM $0.00MM
Net Income(Loss)* $-190.42MM $-58.77MM $-43.44MM
Stockholders Equity $145.78MM $113.31MM $78.81MM
Assets $190.80MM $118.55MM $121.74MM
Operating Cash Flow $-124.45MM $-67.70MM $-38.37MM
Capital expenditure $0.00MM $0.00MM $0.20MM
Investing Cash Flow $37.98MM $95.00MM $-19.72MM
Financing Cash Flow $70.50MM $0.02MM $155.01MM
Earnings Per Share** $-42.09 $-11.73 $-2.85

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.